Clinical Study

Hypertension Control and Cardiometabolic Risk: A Regional Perspective

Table 8

Blood pressure and triglycerides (mmol/L ± SD, adjusted for age, gender, and diabetes).

Total
( )
Northern Europe
( )
Southern Europe
( )
North America
( )
Middle East
( )
Asia
( )
value

SBP (mmHg)
 <1201.5 (0.037)1.6 (0.078)1.6 (0.068)1.5 (0.102)1.3 (0.206)1.7 (0.076)0.4212
 120–1391.7 (0.017)1.8 (0.033)1.6 (0.027)1.8 (0.054)1.7 (0.120)1.8 (0.038)<0.0001
 140–1591.8 (0.014)1.9 (0.025)1.7 (0.023)1.7 (0.054)2.1 (0.075)1.9 (0.036)<0.0001
 160–1791.9 (0.020)2.0 (0.033)1.8 (0.033)1.7 (0.085)2.2 (0.082)2.0 (0.055)<0.0001
 ≥1801.9 (0.034)2.0 (0.055)1.8 (0.057)1.9 (0.157)2.3 (0.134)2.2 (0.097)0.0054
value<0.0001<0.0001<0.00010.16580.00390.0008
DBP (mmHg)
 <901.7 (0.012)1.8 (0.021)1.6 (0.020)1.7 (0.037)1.7 (0.078)1.8 (0.028)<0.0001
 90–991.9 (0.016)2.0 (0.028)1.8 (0.026)1.9 (0.074)2.2 (0.073)1.9 (0.042)<0.0001
 100–1091.9 (0.027)2.0 (0.050)1.8 (0.044)2.0 (0.154)2.3 (0.108)2.1 (0.073)<0.0001
 ≥1101.9 (0.053)1.8 (0.089)1.9 (0.084)1.9 (0.342)2.4 (0.180)2.3 (0.161)0.0073
value<0.0001<0.0001<0.00010.04690.0012<0.0001
RR (mmHg)
 uncontrolled*1.9 (0.014)2.0 (0.018)1.7 (0.017)1.8 (0.043)2.1 (0.050)1.9 (0.028)<0.0001
 controlled**1.7 (0.011)1.7 (0.033)1.6 (0.027)1.7 (0.050)1.7 (0.115)1.8 (0.037)0.0024
value<0.0001<0.0001<0.00010.42550.00250.0081

*SBP/DBP ≥140/90 in non-diabetic and ≥130/80 in diabetic patients, **<140/90 in non-diabetic and <130/80 in diabetic patients.